Rallybio (RLYB) Treasury Shares (2020 - 2026)
Rallybio (RLYB) posted Treasury Shares of $33099.0 for Q1 2026, down 14.26% sequentially from $38603.0 in Q4 2025, and down 97.6% YoY from $1.4 million in Q1 2025.
Rallybio (RLYB) Treasury Shares (2020 - 2026) Analysis & Trends
Rallybio has reported Treasury Shares for 7 years, with the latest figure at $33099.0 in Q1 2026.
- Quarterly Treasury Shares fell 97.6% year-over-year to $33099.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $33099.0 (down 97.6% YoY) and the FY2025 annual result came in at $38603.0, down 70.99% from the prior year.
- Treasury Shares retreated to $33099.0 in Q1 2026 per RLYB's latest filing, from $38603.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $1.7 million in Q1 2022 and troughed at $5680.0 in Q2 2025.
- A 5-year average of $615849.6 and a median of $412965.0 in 2024 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2022 and 2025: Treasury Shares jumped 6330.0% in 2022, then tumbled 98.62% in 2025.
- Over 5 years, Treasury Shares stood at $128600.0 in 2022, then surged by 71.27% to $220250.0 in 2023, then sank by 39.58% to $133069.0 in 2024, then plunged by 70.99% to $38603.0 in 2025, then retreated by 14.26% to $33099.0 in 2026.
- According to Business Quant data, Treasury Shares over the past three periods registered $33099.0, $38603.0, and $722086.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Rallybio | 94.61 Mn | 94.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32,769.00 |
| Jun 30, 2026 | 32,769.00 |
| Mar 31, 2026 | 33,099.00 |
| Mar 31, 2026 | 33,099.00 |
| Dec 31, 2025 | 38,603.00 |
| Dec 31, 2025 | 38,603.00 |
| Sep 30, 2025 | 722,086.00 |
| Sep 30, 2025 | 722,086.00 |
| Jun 30, 2025 | 5,680.00 |
| Jun 30, 2025 | 5,680.00 |
| Mar 31, 2025 | 1.38 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Dec 31, 2024 | 133,069.00 |
| Dec 31, 2024 | 133,069.00 |
| Sep 30, 2024 | 1.03 Mn |
| Sep 30, 2024 | 1.03 Mn |
| Jun 30, 2024 | 412,965.00 |
| Jun 30, 2024 | 412,965.00 |
| Mar 31, 2024 | 403,875.00 |
| Mar 31, 2024 | 403,875.00 |